WHO plans slew of COVID-19 vaccine approvals for global rollout - document

Exclusive: WHO plans slew of COVID-19 vaccine approvals for global rollout - document The World Health Organization (WHO) plans to approve several COVID-19 vaccines from Western and Chinese manufacturers in the coming weeks and months, an internal document seen by Reuters shows, as it aims for rapid rollouts in poorer countries. Francesco Guarascio U.S.

BRUSSELS (Reuters) - The World Health Organization (WHO) plans to approve several COVID-19 vaccines from Western and Chinese manufacturers in the coming weeks and months, an internal document seen by Reuters shows, as it aims for rapid rollouts in poorer countries.

COVAX, a global scheme co-led by the WHO, wants to deliver at least 2 billion COVID-19 doses across the world this year, with at least 1.3 billion going to poorer countries.

But it has so far struggled to secure enough shots due to a shortage of funds, while wealthy nations have booked large volumes of vaccines for themselves.

In the race to deploy shots, regulatory approvals are key to confirming the effectiveness and safety of vaccines, and to boosting output. But some poorer countries rely mostly on WHO authorisations as they have limited regulatory capacity.

The WHO is therefore “expediting” emergency approvals, according to a COVAX internal document, which cites data updated to Jan. 7.

The COVID-19 vaccine developed by AstraZeneca and manufactured by the Serum Institute of India (SII) could be authorised by the WHO in January or February, the document says.

The same vaccine produced in South Korea by SK Bioscience could be approved by the U.N. agency at the end of February, at the earliest, the document says. ...